Harrow Health Inc (NASDAQ:HROW)

5.86
Delayed Data
As of 4:00pm ET
 +0.03 / +0.51%
Today’s Change
1.99
Today|||52-Week Range
7.20
+2.99%
Year-to-Date

Today’s Trading

Previous close5.83
Today’s open5.86
Day’s range5.72 - 6.02
Volume132,292
Average volume (3 months)236,986
Market cap$143.4M
Data as of 4:00pm ET, 06/17/2019

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-84.43%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+54.52%
P/E ratio4.8
Price/Sales3.27
Price/Book5.70

Competitors

 Today’s
change
Today’s
% change
NBRVNabriva Therapeutics...+0.08+4.02%
ADROAduro Biotech Inc+0.10+5.59%
--EcoGreen Internation...0.000.00%
FOMXFoamix Pharmaceutica...+0.11+4.09%
Data as of 4:15pm ET, 06/17/2019

Financials

Next reporting dateAugust 14, 2019
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$41.4M
Annual profit (last year)$14.6M
Net profit margin35.35%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Office &
Director
Mark L. Baum
CFO, Secretary &
Principal Accounting Officer
Andrew R. Boll
Corporate headquarters
San Diego, California

Forecasts